The average hemoglobin level of 26.9g/dL is significantly abnormally elevated, and caution should be exercised against factors such as polycythemia vera, chronic hypoxia, or dehydration. The main influencing factors include myeloproliferative disorders, long-term smoking, high-altitude living, severe diarrhea or burns, etc.
1. Polycythemia vera:
Abnormal proliferation of bone marrow leads to excessive production of hemoglobin, which may be accompanied by symptoms such as headache and skin itching. Diagnosis needs to be confirmed through JAK2 gene testing and bone marrow puncture, and treatment can use drugs such as hydroxyurea to control blood cell count.
2. Chronic hypoxia compensation:
In patients with long-term smoking, chronic obstructive pulmonary disease, or congenital heart disease, the body compensates for hypoxia by increasing hemoglobin. Typical manifestations include cyanosis of the lips and clubbed fingers, requiring improvement in oxygen therapy and treatment for underlying diseases.
3. physiological adaptation to high altitude: Residents living in areas above 3000 meters above sea level may experience physiological hemoglobin elevation, usually accompanied by an increase in hematocrit. It is recommended to regularly monitor blood viscosity and perform intravenous bloodletting treatment if necessary.
4. Severe dehydration state:
Acute gastroenteritis, extensive burns, etc. lead to blood concentration and false increase in test values. Accompanied by decreased urine output and decreased skin elasticity, it is necessary to promptly replenish fluids to correct electrolyte imbalances.
5. Secondary erythrocytosis:
Diseases such as renal cysts and liver tumors may secrete erythropoietin abnormally, which needs to be investigated through abdominal ultrasound and EPO level testing. The treatment should be targeted at the primary disease, and if necessary, bloodletting therapy should be used.
If abnormal elevation of hemoglobin is found, blood routine, iron metabolism, EPO testing and other tests should be completed to avoid vigorous exercise and prevent thrombosis. It is necessary to maintain a daily intake of 2000ml of water, reduce the intake of high-speed rail foods, and regularly monitor blood pressure and hemorheological indicators. Patients with polycythemia vera require lifelong anticoagulant therapy, and it is recommended to have blood tests and liver and spleen ultrasound rechecked every 3 months.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!